𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The potential of radiolabeled EGF-dextran conjugates in the treatment of urinary bladder carcinoma

✍ Scribed by Peter Bue; Marcela Márquez; Per-Uno Malmström; Jan-Erik Westlin; Sten Nilsson; Anders R. Holmberg

Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
128 KB
Volume
80
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis

BACKGROUND.

Muscle-invasive urothelial carcinoma of the urinary bladder has a

📜 SIMILAR VOLUMES

Survival of patients with carcinoma in s
Survival of patients with carcinoma in situ of the urinary bladder
✍ Liang Cheng; John C. Cheville; Roxann M. Neumann; Bradley C. Leibovich; Kathleen 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 2 views

## BACKGROUND. To the authors' knowledge, the long term follow-up of patients with carcinoma in situ of the urinary bladder is limited. ## METHODS. The authors studied 138 patients diagnosed with urothelial carcinoma in situ of the bladder at the Mayo Clinic between 1972-1979. All the histologi

Chromosomal imbalances in small cell car
Chromosomal imbalances in small cell carcinomas of the urinary bladder
✍ Terracciano, Luigi; Richter, Jan; Tornillo, Luigi; Beffa, Lorenza; Diener, Pierr 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

Small cell carcinomas (SCCs) represent a rare histological subtype of urinary bladder cancer. Little is known abut the genetic alterations in these tumours. To identify chromosomal aberrations that are typically present in SCC of the urinary bladder, ten tumours were analysed by comparative genomic

Combined intraarterial chemotherapy and
Combined intraarterial chemotherapy and radiotherapy in the treatment of Bladder carcinoma
✍ Abul Mokarim; Masataka Uetani; Nobuyuki Hayashi; Ichiro Sakamoto; Kazunori Minam 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 1 views

with complete responses were given an additional course of chemotherapy (intra-School of Medicine, Nagasaki, Japan. arterial cisplatin and doxorubicin) and irradiation (20 Gy), and patients with resid-